MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 40 filers reported holding MYMD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,617 | +61.4% | 7,801 | +309.1% | 0.00% | – |
| Q2 2023 | $2,860 | -12.8% | 1,907 | 0.0% | 0.00% | – |
| Q1 2023 | $3,279 | +64.0% | 1,907 | 0.0% | 0.00% | – |
| Q4 2022 | $2,000 | -60.0% | 1,907 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | – | 1,907 | +27142.9% | 0.00% | – |
| Q2 2022 | $0 | – | 7 | +600.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 1 | -99.8% | 0.00% | – |
| Q4 2021 | $2,000 | +100.0% | 407 | +270.0% | 0.00% | – |
| Q3 2021 | $1,000 | – | 110 | +2650.0% | 0.00% | – |
| Q2 2021 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Praetorian Wealth Management, Inc. | 200,000 | $118,400 | 0.04% |
| Atlas Brown,Inc. | 43,500 | $25,752 | 0.01% |
| Taylor & Morgan Wealth Management, LLC | 16,086 | $9,523 | 0.01% |
| Fidelis Capital Partners, LLC | 38,590 | $22,845 | 0.01% |
| Cambria Investment Management, L.P. | 171,570 | $101,569 | 0.01% |
| Corundum Group, Inc. | 19,600 | $11,603 | 0.01% |
| Bridgecreek Investment Management, LLC | 30,000 | $17,760 | 0.00% |
| XTX Topco Ltd | 39,544 | $23,410 | 0.00% |
| WALLED LAKE PLANNING & WEALTH MANAGEMENT, LLC | 14,000 | $8,288 | 0.00% |
| NWAM LLC | 40,000 | $23,680 | 0.00% |